CartiHeal

company

About

CartiHeal is a medical device company manufacturing products to repair articular cartilage and osteochondral defects.

  • 501 - 1000

Details

Last Funding Type
Series C
Last Funding Money Raised
$300K
Industries
Health Care,Manufacturing,Medical Device
Founded date
Jan 1, 2009
Number Of Employee
501 - 1000
Operating Status
Active

CartiHeal, a privately held medical device company headquartered in Israel, is a pioneer in the field of cartilage regeneration. Cartilage injuries affect millions of patients around the world, and characteristically cause severe pain and disability. Hyaline cartilage has a very limited ability to heal once damaged. Research indicates that injuries to joint cartilage, if left untreated, may lead to progressive joint changes and early onset of osteoarthritis. The need for a simple, well-tolerated and effective solution for cartilage repair and regeneration represents one of medicine’s most challenging unmet needs. CartiHeal's flagship Agili-C™ implant represents a significant medical breakthrough. This implant has shown to promote regeneration of true hyaline cartilage and its subchondral bone, simultaneously without the use of cells, growth factors or other exogenous agents. The cell-free implant is inserted arthroscopically or via a minimally-invasive approach.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$300K
CartiHeal has raised a total of $300K in funding over 2 rounds. Their latest funding was raised on Apr 7, 2011 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 7, 2011 Series C $300K 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
CartiHeal is funded by 1 investors. Capikris Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
Capikris Foundation Series C